Search research articles
Contact Us
Filters
Showing results (11-20 of 231) with videos related to
Page
of 24
Sort By:
Diabetologia
|
June 24, 2022
A roadmap to achieve pharmacological precision medicine in diabetes
Jose C Florez, Ewan R Pearson
Endocrinology
|
March 25, 2006
Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes
Andrew T Hattersley, Ewan R Pearson
Diabetes, Obesity & Metabolism
|
November 25, 2018
Reflections on the sulphonylurea story: A drug class at risk of extinction or a drug class worth reviving?
Ruth L M Cordiner, Ewan R Pearson
Diabetologia
|
July 10, 2013
Molecular mechanism of action of metformin: old or new insights?
Graham Rena, Ewan R Pearson, Kei Sakamoto
Handbook of Experimental Pharmacology
|
June 15, 2022
Precision Medicine in Diabetes
Adem Y Dawed, Eram Haider, Ewan R Pearson
Biochemical Pharmacology
|
November 30, 2010
Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology
John R Petrie, Ewan R Pearson, Calum Sutherland
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 14, 2022
The impact of birthweight on subsequent phenotype of type 2 diabetes in later life
Christian Paulina, Louise A Donnelly, Ewan R Pearson
International Journal of Endocrinology
|
December 11, 2013
Pharmacogenetics of oral antidiabetic drugs
Matthijs L Becker, Ewan R Pearson, Ivan Tkáč
The Journal of Clinical Investigation
|
January 16, 2026
GLP-1RA precision medicine in people with type 2 diabetes: current insights and future prospects
Pedro Cardoso, John M Dennis, Ewan R Pearson
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 11, 2025
Exploring the potential role of C-peptide in type 2 diabetes management
YeunYi Lin, Rory J McCrimmon, Ewan R Pearson
Page
of 24
Search research articles
Search
Showing results (11-20 of 231) with videos related to
Sort By:
Page
of 24
Diabetologia
|
June 24, 2022
A roadmap to achieve pharmacological precision medicine in diabetes
Jose C Florez, Ewan R Pearson
Endocrinology
|
March 25, 2006
Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes
Andrew T Hattersley, Ewan R Pearson
Diabetes, Obesity & Metabolism
|
November 25, 2018
Reflections on the sulphonylurea story: A drug class at risk of extinction or a drug class worth reviving?
Ruth L M Cordiner, Ewan R Pearson
Diabetologia
|
July 10, 2013
Molecular mechanism of action of metformin: old or new insights?
Graham Rena, Ewan R Pearson, Kei Sakamoto
Handbook of Experimental Pharmacology
|
June 15, 2022
Precision Medicine in Diabetes
Adem Y Dawed, Eram Haider, Ewan R Pearson
Biochemical Pharmacology
|
November 30, 2010
Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology
John R Petrie, Ewan R Pearson, Calum Sutherland
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 14, 2022
The impact of birthweight on subsequent phenotype of type 2 diabetes in later life
Christian Paulina, Louise A Donnelly, Ewan R Pearson
International Journal of Endocrinology
|
December 11, 2013
Pharmacogenetics of oral antidiabetic drugs
Matthijs L Becker, Ewan R Pearson, Ivan Tkáč
The Journal of Clinical Investigation
|
January 16, 2026
GLP-1RA precision medicine in people with type 2 diabetes: current insights and future prospects
Pedro Cardoso, John M Dennis, Ewan R Pearson
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 11, 2025
Exploring the potential role of C-peptide in type 2 diabetes management
YeunYi Lin, Rory J McCrimmon, Ewan R Pearson
Page
of 24